Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies

Overview of attention for article published in BMC Cancer, March 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Irinotecan-Temozolomide ‘Effective and Safe’ for Relapsed Ewing Sarcoma

Cancer Therapy Advisor, 13 Apr 2022

The combination of irinotecan and temozolomide is active and well tolerated in patients with relapsed Ewing sarcoma, according…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.